Skip to main content

Table 2. Characteristics of patients (n=13) involved in the alpha testing

From: Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development

   N (%)a
Gender Female 10 (77)
Male 3 (23)
Age (years) Mean ±SD 53.9 ±9.0
Range 35-64
Highest educational level Pre-vocational education 3 (23)
Vocational education 3 (23)
Higher education 7 (54)
MS type RRMS 11 (85)
SPMS 2 (15)
Time since MS diagnosis (in years) Mean ±SD 17.0 ±11.6
Range 1-38
Experience with DMDs Yes 13 (100)
No 0 (0)
  1. MS, multiple sclerosis; RRMS, relapsing-remitting multiple sclerosis; SD, standard deviation; SPMS, secondary progressive multiple sclerosis
  2. aUnless otherwise specified